455 related articles for article (PubMed ID: 15076812)
21. The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population.
Stanley J; Sarfati D
J Clin Epidemiol; 2017 Dec; 92():99-110. PubMed ID: 28844785
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Measures to Predict Mortality and Length of Stay in Hospitalized Patients.
Liu J; Larson E; Hessels A; Cohen B; Zachariah P; Caplan D; Shang J
Nurs Res; 2019; 68(3):200-209. PubMed ID: 30882561
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality.
Mnatzaganian G; Ryan P; Norman PE; Hiller JE
J Clin Epidemiol; 2012 Jan; 65(1):107-15. PubMed ID: 21803545
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival.
Chang HJ; Chen PC; Yang CC; Su YC; Lee CC
Medicine (Baltimore); 2016 Feb; 95(7):e2861. PubMed ID: 26886653
[TBL] [Abstract][Full Text] [Related]
25. Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data.
Sharma N; Schwendimann R; Endrich O; Ausserhofer D; Simon M
BMC Health Serv Res; 2021 Jan; 21(1):13. PubMed ID: 33407455
[TBL] [Abstract][Full Text] [Related]
26. Development of comorbidity score for patients undergoing major surgery.
Mehta HB; Yong S; Sura SD; Hughes BD; Kuo YF; Williams SB; Tyler DS; Riall TS; Goodwin JS
Health Serv Res; 2019 Dec; 54(6):1223-1232. PubMed ID: 31576566
[TBL] [Abstract][Full Text] [Related]
27. Inpatient mortality after orthopaedic surgery.
Menendez ME; Neuhaus V; Ring D
Int Orthop; 2015 Jul; 39(7):1307-14. PubMed ID: 25711395
[TBL] [Abstract][Full Text] [Related]
28. Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts.
Lix LM; Quail J; Teare G; Acan B
Osteoporos Int; 2011 Oct; 22(10):2633-43. PubMed ID: 21305268
[TBL] [Abstract][Full Text] [Related]
29. Elixhauser outperformed Charlson comorbidity index in prognostic value after ACS: insights from a national registry.
Zhang F; Chiu Y; Ensor J; Mohamed MO; Peat G; Mamas MA
J Clin Epidemiol; 2022 Jan; 141():26-35. PubMed ID: 34461210
[TBL] [Abstract][Full Text] [Related]
30. Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.
Simard M; Sirois C; Candas B
Med Care; 2018 May; 56(5):441-447. PubMed ID: 29578951
[TBL] [Abstract][Full Text] [Related]
31. Adaptation of the Acute Organ Failure Score for Use in a Medicare Population.
Courtright KR; Halpern SD; Bayes B; Harhay MO; Raneses E; Kipnis P; Escobar GJ; Kerlin MP
Crit Care Med; 2017 Nov; 45(11):1863-1870. PubMed ID: 28777196
[TBL] [Abstract][Full Text] [Related]
32. Cross-national comparative performance of three versions of the ICD-10 Charlson index.
Sundararajan V; Quan H; Halfon P; Fushimi K; Luthi JC; Burnand B; Ghali WA;
Med Care; 2007 Dec; 45(12):1210-5. PubMed ID: 18007172
[TBL] [Abstract][Full Text] [Related]
33. A Comparison of the Charlson and Elixhauser Comorbidity Measures to Predict Inpatient Mortality After Proximal Humerus Fracture.
Menendez ME; Ring D
J Orthop Trauma; 2015 Nov; 29(11):488-93. PubMed ID: 26165266
[TBL] [Abstract][Full Text] [Related]
34. Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases.
Metcalfe D; Masters J; Delmestri A; Judge A; Perry D; Zogg C; Gabbe B; Costa M
BMC Med Res Methodol; 2019 Jun; 19(1):115. PubMed ID: 31170931
[TBL] [Abstract][Full Text] [Related]
35. Predictors of in-hospital mortality following major lower extremity amputations in type 2 diabetic patients using artificial neural networks.
Lopez-de-Andres A; Hernandez-Barrera V; Lopez R; Martin-Junco P; Jimenez-Trujillo I; Alvaro-Meca A; Salinero-Fort MA; Jimenez-Garcia R
BMC Med Res Methodol; 2016 Nov; 16(1):160. PubMed ID: 27876006
[TBL] [Abstract][Full Text] [Related]
36. Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices.
Buhr RG; Jackson NJ; Kominski GF; Dubinett SM; Ong MK; Mangione CM
BMC Health Serv Res; 2019 Oct; 19(1):701. PubMed ID: 31615508
[TBL] [Abstract][Full Text] [Related]
37. Comparison of comorbidity classification methods for predicting outcomes in a population-based cohort of adults with human immunodeficiency virus infection.
Antoniou T; Ng R; Glazier RH; Kopp A; Austin PC
Ann Epidemiol; 2014 Jul; 24(7):532-7. PubMed ID: 24837611
[TBL] [Abstract][Full Text] [Related]
38. Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index.
Moore BJ; White S; Washington R; Coenen N; Elixhauser A
Med Care; 2017 Jul; 55(7):698-705. PubMed ID: 28498196
[TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction.
Snow GL; Bledsoe JR; Butler A; Wilson EL; Rea S; Majercik S; Anderson JL; Horne BD
PLoS One; 2020; 15(5):e0233495. PubMed ID: 32437416
[TBL] [Abstract][Full Text] [Related]
40. Use of comorbidity measures to predict the risk of death in Brazilian in-patients.
Martins M
Rev Saude Publica; 2010 Jun; 44(3):448-56. PubMed ID: 20428601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
